Form 8-K - Current report:
SEC Accession No. 0001193125-23-167868
Filing Date
2023-06-15
Accepted
2023-06-15 16:01:54
Documents
12
Period of Report
2023-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d514530d8k.htm   iXBRL 8-K 32476
  Complete submission text file 0001193125-23-167868.txt   150685

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA teva-20230615.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20230615_lab.xml EX-101.LAB 17168
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20230615_pre.xml EX-101.PRE 10793
6 EXTRACTED XBRL INSTANCE DOCUMENT d514530d8k_htm.xml XML 3367
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 231017294
SIC: 2834 Pharmaceutical Preparations